Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Planned Hematopoietic Cell Transplantation”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Not applicableStudy completedNCT02786628
What this trial is testing

Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation

Who this might be right for
Malignant Solid TumourHematologic MalignanciesPlanned Hematopoietic Cell Transplantation
UNC Lineberger Comprehensive Cancer Center 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT04761770
What this trial is testing

Study of a Geriatric Assessment to Plan a Treatment Approach for Older People With Various Blood Disorders

Who this might be right for
Myelodysplastic SyndromeMyeloproliferative NeoplasmsChronic Myelomonocytic Leukemia+2 more
Memorial Sloan Kettering Cancer Center 33
Not applicableStudy completedNCT00049465
What this trial is testing

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT05972577
What this trial is testing

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAplastic Anemia+9 more
Ohio State University Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT03652064
What this trial is testing

A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 395
Early research (Phase 1)Study completedNCT03984097
What this trial is testing

Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)

Who this might be right for
Multiple Myeloma
Takeda 50
Testing effectiveness (Phase 2)Ended earlyNCT01518153
What this trial is testing

Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphomaMyeloma+1 more
M.D. Anderson Cancer Center 16
Not applicableLooking for participantsNCT05605574
What this trial is testing

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell Transplantation
National Cancer Institute (NCI) 222
Not applicableApproved For MarketingNCT04247906
What this trial is testing

Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab

Who this might be right for
Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA)
Omeros Corporation
Not applicableNot Yet RecruitingNCT07579065
What this trial is testing

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

Who this might be right for
Hematologic NeoplasmHematopoietic Stem Cell TransplantationSurvivorship+1 more
Azienda USL Reggio Emilia - IRCCS 40
Testing effectiveness (Phase 2)Study completedNCT00833560
What this trial is testing

Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose Chemotherapy

Who this might be right for
Multiple Myeloma
Janssen-Cilag G.m.b.H 401
Not applicableStudy completedNCT02200133
What this trial is testing

Randomized Study of Individualized Care Plans for Hematopoietic Cell Transplant Survivors

Who this might be right for
Adult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCT
Center for International Blood and Marrow Transplant Research 495
Large-scale testing (Phase 3)Active Not RecruitingNCT04923893
What this trial is testing

Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 743
Not applicableLooking for participantsNCT07052630
What this trial is testing

Patient Navigation and the Planning Advance Care Together Website to Improve Goals of Care Conversations in Hematopoietic Cell Transplant Survivors, IMPACT-HCT Trial

Who this might be right for
Hematopoietic and Lymphatic System Neoplasm
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00998049
What this trial is testing

Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant

Who this might be right for
Multiple MyelomaRefractory Multiple MyelomaStage I Multiple Myeloma+2 more
Mayo Clinic 40
Not applicableWithdrawnNCT03158467
What this trial is testing

RCT of ACP for Transplant

Who this might be right for
Cancer Patients Undergoing Stem Cell Transplantation (RCT of ACP for Transplant)
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)UnknownNCT04969172
What this trial is testing

A Phase II Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Exosomes Overexpressing CD24 to Prevent Clinical Deterioration in Patients With Moderate or Severe COVID-19 Infection

Who this might be right for
COVID-19 Disease
Eli Sprecher, MD 155
Large-scale testing (Phase 3)Study completedNCT03125070
What this trial is testing

Self-Management Program and Survivorship Care Plan in Improving the Health of Cancer Survivors After Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell Neoplasm
Fred Hutchinson Cancer Center 546